Sophora flower bud (Huaimi) primarily grows in Hennan, Shanxi, Shaanxi and Gansu province, where plenty of huaimi is arriving to the market. But it is an off year in 2012, so the overall production is lower. In early season, huaimi’s low prices dampened farmers’ enthusiasm for picking and selling. Moreover, resellers purchased huaimi at high prices last year. They will not sell huaimi at lower prices. Therefore, hauimi is offered at varied prices in China.
Rutin’s manufacturers are waiting and watching the market. Rutin has been sold at low prices in 2012. So it is impossible for manufacturers to buy huaimi at high prices. The rutin market is still unclear.
Herbridge Media will keep an eye on the market and give a report next month.
Copyright：Herbridge Media
- White Paper on Bone and Joint Health of Chinese Consumers 2020
- Yili Dairy launched high-protein yogurt, focusing on sport people
- Sinopharm Xingsha launched the Japan's Champion probiotics
- China has introduced its first policy to support the industrial hemp industry
- Beyond Meat became the first overseas Artificial Meat company to set up a factory in China
- Nongfu Spring's market value exceeded HK $370 billion on its first day
- German infant nutrition brand Amykon launched two probiotics in China
- The revenue of Besunyoung in the first half year is about 610 million yuan
- Jellly candy and powder included in the health food filing dosage form in China
- H&H Group net profit increased by 9% for the first half of year
